FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2032471331> ?p ?o ?g. }

• W2032471331 endingPage "3134" @default.
• W2032471331 startingPage "3127" @default.
• W2032471331 abstract "Abstract BACKGROUND: The authors evaluated the incidence of pathologic downstaging and complete remission (CR) in patients with high‐grade ureteral and renal pelvic transitional cell carcinoma (TCC) (upper tract TCC) who received neoadjuvant chemotherapy followed by surgery. METHODS: The study group comprised patients with biopsy‐demonstrated, high‐grade disease who received neoadjuvant chemotherapy followed by nephrouterectomy from 2004 to 2008, during which time patients uniformly were considered for neoadjuvant chemotherapy. The control group comprised patients with biopsy‐demonstrated, high‐grade disease who underwent initial nephroureterectomy from 1993 to 2004, when patients uniformly underwent initial surgery. Multiple clinical and pathologic features were evaluated, and the primary endpoint was pathologic tumor classification. RESULTS: One hundred seven patients in the control group underwent initial surgery, and 43 patients in the study group received neoadjuvant chemotherapy. Baseline demographics were similar between the groups except for a higher rate of sessile tumor architecture in the study group (72.1% vs 49.5%; P = .018). There was significant downstaging in study group patients compared with the historic control group ( P = .004). The incidence of tumors classified as pathologic T2 (pT2) or as pT3 or higher was significantly lower in the study group (pT2, 65.4% vs 48.8%; P = .043; pT3 or higher, 47.7% vs 27.9%; P = .029). Fourteen percent of patients who received neoadjuvant chemotherapy had a pathologic CR. CONCLUSIONS: Neoadjuvant chemotherapy was associated with a 14% CR rate and a significant rate of downstaging. While longer follow‐up is awaited for survival data to mature, the current data provide justification for the sustained support of trials using this strategy. Cancer 2010. © 2010 American Cancer Society." @default.
• W2032471331 created "2016-06-24" @default.
• W2032471331 creator A5006702120 @default.
• W2032471331 creator A5017537551 @default.
• W2032471331 creator A5019701713 @default.
• W2032471331 creator A5027897588 @default.
• W2032471331 creator A5034005227 @default.
• W2032471331 creator A5064230008 @default.
• W2032471331 creator A5076525924 @default.
• W2032471331 creator A5085172191 @default.
• W2032471331 creator A5091753897 @default.
• W2032471331 date "2010-04-07" @default.
• W2032471331 modified "2023-10-16" @default.
• W2032471331 title "Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma" @default.
• W2032471331 cites W1974484906 @default.
• W2032471331 cites W1975918912 @default.
• W2032471331 cites W1980525903 @default.
• W2032471331 cites W1987806240 @default.
• W2032471331 cites W1990070131 @default.
• W2032471331 cites W2000415625 @default.
• W2032471331 cites W2006030842 @default.
• W2032471331 cites W2008296900 @default.
• W2032471331 cites W2008911129 @default.
• W2032471331 cites W2010188406 @default.
• W2032471331 cites W2010513628 @default.
• W2032471331 cites W2023720884 @default.
• W2032471331 cites W2051346092 @default.
• W2032471331 cites W2051577701 @default.
• W2032471331 cites W2053031377 @default.
• W2032471331 cites W2067622576 @default.
• W2032471331 cites W2077825533 @default.
• W2032471331 cites W2088929974 @default.
• W2032471331 cites W2098028863 @default.
• W2032471331 cites W2120309176 @default.
• W2032471331 cites W2121543824 @default.
• W2032471331 cites W2132907440 @default.
• W2032471331 cites W2151508785 @default.
• W2032471331 cites W2157244703 @default.
• W2032471331 cites W2314188319 @default.
• W2032471331 doi "https://doi.org/10.1002/cncr.25050" @default.
• W2032471331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20564621" @default.
• W2032471331 hasPublicationYear "2010" @default.
• W2032471331 type Work @default.
• W2032471331 sameAs 2032471331 @default.
• W2032471331 citedByCount "206" @default.
• W2032471331 countsByYear W20324713312012 @default.
• W2032471331 countsByYear W20324713312013 @default.
• W2032471331 countsByYear W20324713312014 @default.
• W2032471331 countsByYear W20324713312015 @default.
• W2032471331 countsByYear W20324713312016 @default.
• W2032471331 countsByYear W20324713312017 @default.
• W2032471331 countsByYear W20324713312018 @default.
• W2032471331 countsByYear W20324713312019 @default.
• W2032471331 countsByYear W20324713312020 @default.
• W2032471331 countsByYear W20324713312021 @default.
• W2032471331 countsByYear W20324713312022 @default.
• W2032471331 countsByYear W20324713312023 @default.
• W2032471331 crossrefType "journal-article" @default.
• W2032471331 hasAuthorship W2032471331A5006702120 @default.
• W2032471331 hasAuthorship W2032471331A5017537551 @default.
• W2032471331 hasAuthorship W2032471331A5019701713 @default.
• W2032471331 hasAuthorship W2032471331A5027897588 @default.
• W2032471331 hasAuthorship W2032471331A5034005227 @default.
• W2032471331 hasAuthorship W2032471331A5064230008 @default.
• W2032471331 hasAuthorship W2032471331A5076525924 @default.
• W2032471331 hasAuthorship W2032471331A5085172191 @default.
• W2032471331 hasAuthorship W2032471331A5091753897 @default.
• W2032471331 hasConcept C120665830 @default.
• W2032471331 hasConcept C121332964 @default.
• W2032471331 hasConcept C121608353 @default.
• W2032471331 hasConcept C126322002 @default.
• W2032471331 hasConcept C126894567 @default.
• W2032471331 hasConcept C141071460 @default.
• W2032471331 hasConcept C168563851 @default.
• W2032471331 hasConcept C203092338 @default.
• W2032471331 hasConcept C2775934546 @default.
• W2032471331 hasConcept C2776694085 @default.
• W2032471331 hasConcept C2777546739 @default.
• W2032471331 hasConcept C2778292576 @default.
• W2032471331 hasConcept C530470458 @default.
• W2032471331 hasConcept C61511704 @default.
• W2032471331 hasConcept C71924100 @default.
• W2032471331 hasConceptScore W2032471331C120665830 @default.
• W2032471331 hasConceptScore W2032471331C121332964 @default.
• W2032471331 hasConceptScore W2032471331C121608353 @default.
• W2032471331 hasConceptScore W2032471331C126322002 @default.
• W2032471331 hasConceptScore W2032471331C126894567 @default.
• W2032471331 hasConceptScore W2032471331C141071460 @default.
• W2032471331 hasConceptScore W2032471331C168563851 @default.
• W2032471331 hasConceptScore W2032471331C203092338 @default.
• W2032471331 hasConceptScore W2032471331C2775934546 @default.
• W2032471331 hasConceptScore W2032471331C2776694085 @default.
• W2032471331 hasConceptScore W2032471331C2777546739 @default.
• W2032471331 hasConceptScore W2032471331C2778292576 @default.
• W2032471331 hasConceptScore W2032471331C530470458 @default.
• W2032471331 hasConceptScore W2032471331C61511704 @default.
• W2032471331 hasConceptScore W2032471331C71924100 @default.
• W2032471331 hasIssue "13" @default.

• next